SUNDAY, SEPTEMBER 24, 2017

New study finds potential alternative treatment for HIV

HIV Read More »

Colombia first country in the world to eradicate river blindness

Merck celebrated on Wednesday the government of Colombia for becoming the first country to eliminate Onchocerciasis, or river blindness. Read More »

Smallpox survivor Ali Maow Maalin passes away

Ali Maow Maalin Read More »

Novavax announced positive preclinical trial for H7N9 influenza vaccine

Novavax announced on July 29 a positive preclinical trial for its virus-like particle vaccine candidate against the H7N9 Influenza A, which protected 100 percent of the mice studied in the trial from infection. Read More »

Emergent BioSolutions closes on acquisition of Bracco Diagnostics division

Emergent BioSolutions, Inc., a Rockville, Maryland-based specialty pharmaceutical company, announced on Friday that it closed on its acquisition of the Healthcare Protective Products Division of Bracco Diagnostics, Inc. Read More »

Nucleus Medical Media uses animation to raise awareness of adult vaccines

Nucleus Medical Media, Inc., a creator of interactive medical multimedia, announced on Wednesday that it created free informational medical animations for National Immunization Awareness Month to explain and promote health literacy. Read More »

Charlize Theron calls for action against AIDS

Charlize Theron Read More »

New study shines light on a treatment of staph infections for CGD patients

A new study conducted by the National Institute of Health's National Institute of Diabetes and Digestive and Kidney diseases found that white blood cells fight off staphylococcus aureus when missing a specific protein. Read More »

U.N. secretary-general appoints former Ugandan VP as HIV/AIDS envoy

Speciosa Wandira-Kasibwe Read More »

Novartis announces age indication expansion for meningococcal vaccine

Novartis, a Basel, Switzerland-based healthcare solutions company, announced on Thursday that the U.S. Food and Drug Administration approved the company's quadrivalent meningococcal vaccine for children as young as two months of age. Read More »

Cell phones battle malaria in Zambia

The Bill and Melinda Gates Foundation showed on Thursday how cell phones are being used in Zambia to fight malaria. Read More »

CDC releases report on vaccine coverage for kindergarteners

The Centers for Disease Control and Prevention released a report on Friday, giving the statistics of vaccine coverage for kindergarteners in the 2012-2013 school year. Read More »

GAVI, WHO and UNICEF introduce pneumococcal vaccine in Sudan

With help from the GAVI Alliance, World Health Organization and UNICEF, the Sudanese Ministry of Health began a nationwide pneumococcal conjugate vaccination program on Thursday targeting approximately 1.3 million infants. Read More »

Researchers identify four-point test to predict C. difficile death risk

Clostridium difficile Read More »

WHO issues update on MERS-CoV

The World Health Organization issued an update on Thursday on the Middle East respiratory syndrome coronavirus. Read More »

iBio receives patent approval for its iBio Modulator system

iBio, Inc., announced on Monday that its patent application, titled "Recombinant Carrier Molecule for Expression, Delivery and Purification of Target Polypeptides," was approved by the U.S. Patent and Trademark Office. Read More »

Researchers find CDC underestimated antibiotic resistance of infections

Researchers with the Los Angeles Biomedical Research Institute recently found that the increase in antibiotic resistance among hospital-acquired infections is higher than previously estimated, according to an article in Antimicrobial Agents and Chemotherapy. Read More »

Meningitis Angels praise FDA's expanded approval of Menveo

Meningitis Angels, a national meningitis-focused non-profit organization, announced on Monday that it was celebrating the recent U.S. Food and Drug Administration decision to expand approval of the Menveo meningitis vaccine. Read More »

Zoetis receives approval for Rui Lan An

Zoetis announced on Monday that it has received approval from the Ministry of Agriculture of the People's Republic of China for Rui Lan An, a vaccine that fights the highly pathogenic porcine reproductive and respiratory syndrome. Read More »

Sanofi Pasteur begins Phase III trials of investigational drug against CDI

Sanofi Pasteur announced on Monday that it will begin Phase III clinical trials of its Cdiffense program, which seeks to develop an investigational vaccine against the leading cause of healthcare-associated infections worldwide Clostridium Difficile. Read More »